Zobrazeno 1 - 10
of 282
pro vyhledávání: '"Naomi Kiyota"'
Autor:
Tomoya Yokota, Sadamoto Zenda, Takeshi Kodaira, Naomi Kiyota, Yasushi Fujimoto, Koichiro Wasano, Ryo Takahashi, Takashi Mizowaki, Akihiro Homma, Keita Sasaki, Ryunosuke Machida, Yuta Sekino, Haruhiko Fukuda, Japan Clinical Oncology Group Radiation Therapy Study Group, Japan Clinical Oncology Group Head and Neck Cancer Study Group
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Chemoradiotherapy (CRT) with concurrent cisplatin is the standard of care as a nonsurgical definitive treatment for patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). However, CRT is associated
Externí odkaz:
https://doaj.org/article/64f26ab6387144ab912b9f48270258b6
Autor:
Satoshi Seno, Kazuma Iwashita, Akifumi Kajiwara, Rie Sasaki, Tatsuya Furukawa, Masanori Teshima, Hirotaka Shinomiya, Naomi Kiyota, Rod Lynch, Kenji Yoshida, Takeaki Ishihara, Daisuke Miyawaki, Ken-ichi Nibu, Ryohei Sasaki
Publikováno v:
Cancers, Vol 16, Iss 10, p 1850 (2024)
Anterior commissure is involved in about 20% of early-stage glottic squamous cell carcinomas (EGSCCs). Treatment outcomes and prognostic factors for EGSCC with anterior commissure involvement (ACI) were evaluated by focusing on hyperfractionated radi
Externí odkaz:
https://doaj.org/article/7a8dd57c656c41638ae9f1014f3a2ff9
Autor:
Masanori Teshima, Hirotaka Shinomiya, Hidehito Kimura, Kazunobu Hashikawa, Naomi Kiyota, Daisuke Miyawaki, Ryohei Sasaki, Eiji Kohmura, Ken‐ichi Nibu
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 6, Pp 1347-1352 (2021)
Abstract Purpose To investigate the oncological outcomes of orbital malignant tumors invading the skull base. Methods A retrospective analysis was conducted on 16 patients with orbital malignant tumors invading the skull base. Eleven patients were tr
Externí odkaz:
https://doaj.org/article/58db736a2ae6458d85a384cfbca066ec
Autor:
Hiroaki Ikeda, Hiroshi Shiku, Shigehisa Kitano, Koji Kato, Shinichi Kageyama, Yoshihiro Miyahara, Mikiya Ishihara, Kazuto Takesako, Takashi Watanabe, Akihiko Matsumine, Makoto Endo, Tomomi Yamada, Satoshi Okumura, Naomi Kiyota, Kimikazu Yakushijin, Kohichi Takada, Shinichiro Kobayashi, Yasuhiro Nagata, Taizo Shiraishi, Keizo Horibe, Hiroshi Miwa
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Introduction Adoptive cell transfer of genetically engineered T cells is a promising treatment for malignancies; however, there are few ideal cancer antigens expressed on the cell surface, and the development of chimeric antigen receptor T cells (CAR
Externí odkaz:
https://doaj.org/article/bb9809a70ebe4968b8c6ed77e521b719
Autor:
Katherine J. Taylor, Cecilie D. Amdal, Kristin Bjordal, Guro L. Astrup, Bente B. Herlofson, Fréderic Duprez, Ricardo R. Gama, Alexandre Jacinto, Eva Hammerlid, Melissa Scricciolo, Femke Jansen, Irma M. Verdonck-de Leeuw, Giuseppe Fanetti, Orlando Guntinas-Lichius, Johanna Inhestern, Tatiana Dragan, Alexander Fabian, Andreas Boehm, Ulrike Wöhner, Naomi Kiyota, Maximilian Krüger, Pierluigi Bonomo, Monica Pinto, Sandra Nuyts, Joaquim C. Silva, Carmen Stromberger, Francesco Tramacere, Ayman Bushnak, Pietro Perotti, Michaela Plath, Alberto Paderno, Noa Stempler, Maria Kouri, Susanne Singer
Publikováno v:
Healthcare, Vol 11, Iss 6, p 906 (2023)
The long-term problems of head and neck cancer survivors (HNCS) are not well known. In a cross-sectional international study aimed at exploring the long-term quality of life in this population, 1114 HNCS were asked to state their two most serious lon
Externí odkaz:
https://doaj.org/article/7cc865ddd9964f1aa51c4681900f3a77
Autor:
Hikaru Kubota, Daisuke Miyawaki, Naritoshi Mukumoto, Takeaki Ishihara, Megumi Matsumura, Takumi Hasegawa, Masaya Akashi, Naomi Kiyota, Hirotaka Shinomiya, Masanori Teshima, Ken-ichi Nibu, Ryohei Sasaki
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background To evaluate factors associated with osteoradionecrosis of the jaw (ORNJ) in patients with head and neck squamous cell carcinoma (HNSCC), focusing on jaw-related dose–volume histogram (DVH) parameters. Methods We retrospectively
Externí odkaz:
https://doaj.org/article/d64fd49513fd42be80240179cd4998d2
Autor:
Takeshi Ioroi, Naomi Kiyota, Yoshinori Imamura, Masaaki Tanda, Shiori Aoki, Mamoru Okuno, Kazuhiro Yamamoto, Ryohei Sasaki, Ken-ichi Nibu, Hironobu Minami, Midori Hirai, Ikuko Yano
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 6, Iss 1, Pp 1-8 (2020)
Abstract Background Oral mucositis frequently occurs in cancer patients treated with chemotherapy and chemoradiotherapy (CRT). This study examined the safety and efficacy of ibuprofen gargle in healthy volunteers and patients with chemotherapy- and c
Externí odkaz:
https://doaj.org/article/29a708ee4e4340a48eeba10dc14bc6e1
Autor:
Haruhiko Otsuka, Takeshi Fukumoto, Naomi Kiyota, Chihiro Takemori, Haruki Jimbo, Chikako Nishigori
Publikováno v:
Dermatology Reports (2021)
Regorafenib is an oral multikinase inhibitor targeting several tyrosine kinase receptors including BRAF and epidermal growth factor receptor (EGFR), and is approved as a third-line treatment for metastatic gastrointestinal stromal tumor (GIST). While
Externí odkaz:
https://doaj.org/article/75d3e375a26446b59675a2e633c25322
Autor:
Chiaki Suzuki, Naomi Kiyota, Yoshinori Imamura, Hideaki Goto, Hirotaka Suto, Naoko Chayahara, Masanori Toyoda, Yasuhiro Ito, Akihiro Miya, Akira Miyauchi, Masanori Teshima, Naoki Otsuki, Ken-ichi Nibu, Hironobu Minami
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundWe previously reported that a high tumor burden is a prognostic factor based on an analysis of 26 patients with radioactive iodine-refractory differentiated thyroid cancer (RR-DTC) who were treated with lenvatinib. However, the optimal tumo
Externí odkaz:
https://doaj.org/article/0472ad3ccd2646a489bf7c687870b4b0
Autor:
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Marika Watanabe, Akihito Kitao, Yoshiharu Miyata, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Taiji Koyama, Yoshinori Imamura, Naomi Kiyota, Hiroshi Matsuoka, Yasuko Mori, Hironobu Minami
Publikováno v:
Vaccines, Vol 10, Iss 6, p 965 (2022)
Anti-CD20 antibodies react with CD20 expressed not only on malignant B cells, but also on normal B cells. It has been reported that patients treated with anti-CD20 antibodies had an insufficient response to two-dose mRNA SARS-CoV-2 vaccination. To in
Externí odkaz:
https://doaj.org/article/452ec6511a854f808107aae63f8f0407